Please assess the completion status of the following clinical trial:

Trial Title: Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men or women 18 years old or older of any ethnic background~* Subjects that have recently undergone a standard in the sleep-lab diagnostic polysomnography (per standard of care medical guidelines), or the at home diagnostic test, and have been diagnosed with OSA~Exclusion Criteria:~* Pregnant or Breastfeeding women~* Women of Child Bearing Potential who are not willing to undergo methods to prevent pregnancy~* Subjects who are on medications that affect cardiac autonomic function (eg. Beta Blockers)~* Active smokers~* Subjects who are unable to read or answer questions in the English language

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Visit 1 Randomization (Type: EXPERIMENTAL): At visit 1 (PSG 1) subjects will receive one of two interventions: either Oxytocin Intranasal Spray (40 IU) or Placebo Intranasal Spray. Subjects will be blinded as to which drug they are receiving.
- Visit 2: Crossover Randomization (Type: EXPERIMENTAL): At visit 2 (PSG 2) subjects will receive the opposite intervention from the one they received at visit 1: either Oxytocin Intranasal Spray (40 IU) or Placebo Intranasal Spray. Subjects will be blinded as to which drug they are receiving.

Based on this trial design, predict the completion outcome and termination type (if applicable).